HNRNPA2B1 and glioblastoma: Deng et al. [91] demonstrated that HNRNPA2B1 knockdown could reduce the expression of phosphorylated STAT3 and MMP2 and decrease the viability, adhesion, migration, invasion, and TMZ resistance of GBM, which induces apoptosis and reactive oxygen species generation in tumor cells.